Advertisement
Advertisement

PHIO

PHIO logo

Phio Pharmaceuticals Corp. Common Stock

1.02
USD
Sponsored
-0.02
-1.92%
Jun 24, 15:57 UTC -4
Closed
exchange

Pre-Market

1.06

+0.04
+3.53%

PHIO Earnings Reports

Positive Surprise Ratio

PHIO beat 24 of 31 last estimates.

77%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.36
Implied change from Q1 26 (Revenue/ EPS)
--
/
+5.88%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-20.00%

Phio Pharmaceuticals Corp. Common Stock earnings per share and revenue

On Apr 01, 2026, PHIO reported earnings of -0.34 USD per share (EPS) for Q1 26, missing the estimate of -0.23 USD, resulting in a -41.84% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.56% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an increase of 5.88% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Phio Pharmaceuticals Corp. Common Stock reported EPS of -$0.34, missing estimates by -41.84%, and revenue of $0.00, 0% as expectations.
The stock price moved up 6.56%, changed from $1.22 before the earnings release to $1.30 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on -- analysts, Phio Pharmaceuticals Corp. Common Stock is expected to report EPS of -$0.36 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement